A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).

A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005). - Phase I study of vinorelbine and thoracic radiotherapy in elderly patients with locally advanced NSCLC.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001392

Enrollment

Registered

2008-09-26

Start date

2006-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Vinorelbine+ Thoracic radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: StageIIB(T3N0M0),IIIA,orIIIB NSCLC. No previous treatment Measurable lesion At least 71 years Performance status 0-1 Adequate organ function Written informed consent

Exclusion criteria

Exclusion criteria: Interstitial pneumonia. No eligibility for definitive radiotherapy.

Design outcomes

Primary

Measure	Time frame
To determine recommended dose	—

Secondary

Measure	Time frame
Safety, Response rate, 2-year survival rate, progression free suevival.	—

Countries

Japan

Contacts

Public ContactShinichiro Nakamura

West Japan Oncology Group WJOG datacenter

datacenter@wjog.jp06-6633-7400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026